作为抗瘤剂的他类药物:重新定位药物的范例
Sneha Tripathi1, Ekta Gupta1, Sanjeev Galande1,2
1Laboratory of Chromatin Biology & Epigenetics, Indian Institute of Science Education and Research, Pune, India.
Cancer reports (Hoboken, N.J.)
|May 7, 2024
概括
降胆固醇药物类药物,通过向癌细胞生长途径,显示出作为抗癌剂的前景. 需要进一步的研究来证实它们在临床环境中的有效性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 类药物抑制HMG-CoA减少酶 (HMGCR) 在美酸盐路径中,主要用于降低胆固醇.
- 由于其安全性,成本效益和疗效,正在探索用于癌症治疗的重新定位他类药物.
- 癌细胞通常依赖于美酸途径的生长和生存.
研究的目的:
- 为了探索除了降低胆固醇之外,他类药物的抗癌特性.
- 研究他类药物影响癌细胞信号通路的机制.
- 评估他类药物作为常规癌症治疗的辅助药物的潜力.
主要方法:
- 对癌症中他类药物的机制现有研究的审查.
- 对他类药物对细胞亡,细胞循环调节和表观遗传学的影响的分析.
- 检查潜在的化疗预防作用和对瘤复发的影响.
主要成果:
- 类药物通过BCL2通路向细胞亡,并通过p53-YAP轴调节细胞循环.
- 类他类药物通过改变DNA甲基化和基因素乙化来诱导表观遗传修饰.
- 初步数据表明,他类药物可能会减少瘤复发并提高生存率.
- 需要进一步的大规模临床研究才能得出最终的结论.
结论:
- 类药物表现出独立于它们降胆固醇效应的抗癌潜力.
- 类药物可以增强传统的癌症治疗方法,克服它们的局限性.
- 对他类药物对促进癌症通路的影响进行进一步的研究是有必要的.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
652
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


